Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
N4 Pharma ( (GB:N4P) ) has provided an update.
N4 Pharma plc announced an Investor Insight Event for retail investors, scheduled for July 14, 2025, at the Royal College of Surgeons in London. The event aims to provide a strategic update on the development of Nuvec® as a delivery system for RNA therapeutics, featuring presentations from the CEO and senior leadership team, followed by a Q&A session and networking lunch. This initiative highlights the company’s commitment to engaging with stakeholders and advancing its position in the biotech industry.
More about N4 Pharma
N4 Pharma plc is a UK-based biotechnology company focused on developing Nuvec®, a proprietary gene delivery system designed to enhance advanced therapies for cancer and other diseases.
Average Trading Volume: 1,718,567
Technical Sentiment Signal: Sell
Current Market Cap: £5.71M
For a thorough assessment of N4P stock, go to TipRanks’ Stock Analysis page.